These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15784309

  • 1. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE, Sens K, Mietzner S, Obman A, Yu VL.
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F, Akamine M, Haranaga S, Tohyama M, Shinzato T, Tateyama M, Koide M, Saito A, Fujita J.
    J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
    [Abstract] [Full Text] [Related]

  • 3. Legionella: macrolides or quinolones?
    Pedro-Botet L, Yu VL.
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():25-30. PubMed ID: 16669926
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J, St-Pierre C.
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [Abstract] [Full Text] [Related]

  • 5. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE, Arnold B, Yu VL.
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Higa F, Edelstein MA.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
    [Abstract] [Full Text] [Related]

  • 7. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
    Yu LL, Hu BJ, Huang SL, Zhou ZY, Tao LL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest.
    Schrock J, Hackman BA, Plouffe JF.
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):221-3. PubMed ID: 9327252
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
    Miyashita N, Kobayashi I, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Ogasawara K, Kurachi S, Ishikawa T, Ishimura Y, Kanesaka I, Kiyota H, Watanabe A.
    J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
    Baltch AL, Bopp LH, Smith RP, Michelsen PB, Ritz WJ.
    J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH, Edelstein MA.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [Abstract] [Full Text] [Related]

  • 13. Review of azithromycin activity against Legionella spp.
    Edelstein PH.
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [Abstract] [Full Text] [Related]

  • 14. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
    Stout JE, Arnold B, Yu VL.
    J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of severe respiratory infection. Legionella pneumonia].
    Saito A.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility study of BMS-284756 against Legionella species.
    Dubois J, St-Pierre C.
    Diagn Microbiol Infect Dis; 2001 Mar; 41(1-2):79-82. PubMed ID: 11687318
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
    Sato T, Tateda K, Kimura S, Ishii Y, Yamaguchi K.
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.